The premium of a big pharma license deal
Crossref DOI link: https://doi.org/10.1038/nbt.2946
Published Online: 2014-07-08
Published Print: 2014-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
O'Connell, Kara E
Frei, Patrik
Dev, Kumlesh K
Text and Data Mining valid from 2014-07-01
Article History
First Online: 8 July 2014
Competing interests
: P.F. is CEO of Venture Valuation, Zurich, Switzerland.